Ontology highlight
ABSTRACT: Background
Pyrazinamide is one of four first-line antibiotics used to treat tuberculosis; however, antibiotic susceptibility testing for pyrazinamide is challenging. Resistance to pyrazinamide is primarily driven by genetic variation in pncA, encoding an enzyme that converts pyrazinamide into its active form.Methods
We curated a dataset of 664 non-redundant, missense amino acid mutations in PncA with associated high-confidence phenotypes from published studies and then trained three different machine-learning models to predict pyrazinamide resistance. All models had access to a range of protein structural-, chemical- and sequence-based features.Results
The best model, a gradient-boosted decision tree, achieved a sensitivity of 80.2% and a specificity of 76.9%
SUBMITTER: Carter JJ
PROVIDER: S-EPMC10946228 | biostudies-literature | 2024 Apr
REPOSITORIES: biostudies-literature